About Synthesis Capital
Synthesis Capital is a venture capital firm founded in 2021. It is primarily based out of London, United Kingdom. As of Dec 2025, Synthesis Capital is an active investor, having invested in 9 companies, with 2 new investments in the last 12 months. It primarily invests in Series C round in United States based startups. Its investments are spread across a wide range of sectors from Food and Agriculture Tech to High Tech and Environment Tech. Most recently it participated in the $***** Series C round of Culture Biosciences Overall, Synthesis Capital portfolio has seen 1 unicorn, namely Upside Foods. A lot of funds co-invest with Synthesis Capital, with names like ADG sharing a substantial percentage of its portfolio. Synthesis Capital has team of 8 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 3 more
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Synthesis Capital's List of Top Investments
Synthesis Capital has a portfolio of 9 companies, one of which is a Unicorn. Their most notable investments are in Arkeon and Equinom.Their portfolio spans across United States, Israel and Austria. They have invested in Food and Agriculture Tech, High Tech, Environment Tech and 6 other sectors, across stages such as Seed, Series A and 3 more. Here is the list of top investments by Synthesis Capital:Provider of biomanufacturing hardware and software tools for research purposes. They have developed the digital biomanufacturing platform by integrating automated bioreactors, robotic sample handling, and cloud data monitoring. It offers services such as strain screening, media optimization, and process development.
Key facts about Culture Biosciences
- Founded Year: 2016
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $107M
- Employee Count: 61 as on Aug 31, 2026
- Investors: Northpond Ventures, Compound and 22 Others
- Latest Funding Round: Series C, Dec 16, 2025, $*****
- Highlight: Editors' Pick
2. Aleph Farms
Develops lab-cultured meat products using beef cells. Its product offerings include ground meat, beef burger patties, steaks, etc. The company uses proprietary 3D bioprinting technologies by using fat cells, support cells, muscle cells, and blood vessel cells to develop tissues and further into meat products. Claims that the process takes 3 weeks to develop the meat in bioreactors.
Key facts about Aleph Farms
- Founded Year: 2017
- Location: Ashdod (Israel)
- Stage: Series B
- Total Funding till date: $118M
- Employee Count: 55 as on Aug 31, 2026
- Investors: La Maison Partners, Lansdowne Partners and 55 Others
- Latest Funding Round: Series B, Jun 07, 2023, $*****
- Highlight: Editors' Pick
3. Upside Foods
Provider of cell-based meat alternatives. Its product offering includes beef meatballs, seafood, duck, chicken, and more.
Key facts about Upside Foods
- Founded Year: 2015
- Location: Berkeley (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $612M
- Employee Count: 230 as on Aug 31, 2026
- Investors: Baillie Gifford, Atomico and 45 Others
- Latest Funding Round: Series C, Apr 21, 2022, $*****
- Highlight: Editors' Pick
Provider of 3D-printed meat. It is a meat processing company using 3D technology and delivers animal-free meat with the same appearance, texture, and flavor by using food ingredients. It provides 3D meat digital modeling, food formulations, and food printing technology.
Key facts about Redefine Meat
- Founded Year: 2018
- Location: Ness Ziona (Israel)
- Stage: Series A
- Total Funding till date: $180M
- Employee Count: 131 as on Aug 31, 2026
- Investors: Hanaco Ventures, Intercap and 12 Others
- Latest Funding Round: Series A, Jan 31, 2022, $*****
- Highlight: Editors' Pick
5. Savor
Provider of delightfully rich foods without animals, farmland, fertilizers, hormones, or antibiotics.
Key facts about Savor
- Founded Year: 2010
- Location: San Jose (United States)
- Stage: Series B
- Total Funding till date: $33M
- Employee Count: 123 as on Aug 31, 2026
- Investors: Climate Capital, Breakthrough Energy and 1 Other
- Latest Funding Round: Series B, Oct 15, 2025, $*****
Synthesis Capital's Year-on-Year Investment Trends
Synthesis Capital has invested in 9 companies over the last 4 years, with an average of 1 new investment annually in the last 3 years. In 2025, it made 2 investments. Its most recent first time investment was in Culture Biosciences and most recent follow-on round was in Arkeon.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 2 | 0 | 2 |
2024 | 0 | 0 | 0 |
2023 | 2 | 0 | 2 |
2022 | 4 | 1 | 5 |
Synthesis Capital's Investments by Stage
Synthesis Capital has made 2 investments in Seed stage with an average round size of $8.77M, 2 investments in Series A stage with an average round size of $78M, 2 investments in Series C stage with an average round size of $400M, 1 investment in Series B stage with an average round size of $33M and 1 investment in Series D stage with an average round size of $35M.Stage of entry | No. of Investments |
|---|---|
Seed | 2 |
Series A | 2 |
Series C | 2 |
Series B | 1 |
Series D | 1 |
Note: We have considered here, only first round of investments
Synthesis Capital's Investments by Sector
Synthesis Capital has a diverse portfolio, with companies operating in the Food and Agriculture Tech, High Tech, Sustainability Tech, Food and Agriculture and Life Sciences. Notably, it has invested in 7 Tech companies, 5 Enterprise (B2B) companies, 3 Consumer (B2C) companies and at least 1 company focusing on Saas.Sector | No. of Investments |
|---|---|
Food and Agriculture Tech | 4 |
High Tech | 4 |
Sustainability Tech | 4 |
Food and Agriculture | 3 |
Life Sciences | 3 |
Others | 7 |
Note: We have considered here, only first round of investments
Synthesis Capital's Investments by Geography
Synthesis Capital has made most investments in United States (5), followed by Israel where it has made 2 investments.Country | No. of Investments |
|---|---|
United States | 5 |
Israel | 2 |
Austria | 1 |
Note: We have considered here, only first round of investments
Synthesis Capital's recent investments
Synthesis Capital has not made any investment in 2026 so far.Here are the most recent investments by Synthesis Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 16, 2025 | United States | Series C | 4212 | [+2] | |
Oct 15, 2025 | United States | Series B | 9991 | ||
Oct 16, 2023 | United States | Series A | 1722 | [+3] | |
Jun 22, 2023 | United States | Seed | 7261 | [+5] | |
Dec 23, 2022 | Austria | Seed | 8375 | [+3] |
Unicorns in Synthesis Capital's Portfolio
Synthesis Capital has 1 unicorn in its portfolio - Upside Foods. The most recent unicorn in their portfolio is Upside Foods which became a unicorn in 2022.Here is a list of unicorns in Synthesis Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
59 | Provider of cell-based meat alternatives | 2015 | Berkeley | Series C | rmhd{sn |
Team profile of Synthesis Capital
Synthesis Capital has a team of 8 members including 2 Partners and 1 Principal located in United Kingdom and United States. Synthesis Capital's team sits on the board of 1 company.Here is a list of all team members in Synthesis Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | London | - | ||
Partner | Frederick | |||
Principal | London | - |
Co-investors of Synthesis Capital
Over the past 4 years, 95 investors have co-invested in Synthesis Capital's portfolio companies. This includes funds and angels.
- Invested before Synthesis Capital: CPT Capital, Cultivian Sandbox and 61 others have invested in rounds before Synthesis Capital. There are 2 companies where CPT Capital has invested before Synthesis Capital and 1 company where Cultivian Sandbox has invested before Synthesis Capital.
- Top Co-investors of Synthesis Capital: 26 investors entered a company along with Synthesis Capital. These include investors like ADG (1 company).
- Invested after Synthesis Capital: A total of 6 investors have invested in Synthesis Capital's portfolio after their investments. Top Investors include Rabobank (1 company), ICL Planet Startup Hub (1 company) and ICL (1 company).
Recent News related to Synthesis Capital
•
Culture Biosciences Closes Series C Round to Expand Stratyx 250 and Console PlatformGlobeNewswire•Dec 16, 2025•Culture Biosciences, Cultivian Sandbox, Synthesis Capital, Northpond Ventures and 1 other
•
•
•
Rabobank Boosts Triplebar’s Funding Round to $21M to Speed Up Food Tech InnovationGrit Daily News•Jan 10, 2024•Triplebar, Rabobank, Synthesis Capital, Essential Capital and 2 others
•
Triplebar: $20 Million In Funding Raised To Improve Nutrition And Disease Treatment OutcomesPulse 2.0•Nov 03, 2023•Triplebar, Synthesis Capital, Essential Capital, Stray Dog Capital and 3 others
•
Triplebar Raises $20M in FinancingFinSMEs•Oct 30, 2023•Triplebar, Synthesis Capital, Essential Capital, Stray Dog Capital and 2 others
•
•
Hyfé raises $9m to transform wastewater into next gen feedstocks for biomanufacturingAgFunderNews•Jun 23, 2023•Hyfe, Synthesis Capital, Engine, Refactor Capital and 5 others
•
Equinom Secures $35 Million in Funding Led by Synthesis CapitalBusiness Wire•Dec 12, 2022•Equinom, Synthesis Capital, Praesidium, Bunge and 6 others
•
Aleph Farms Is Newest Aim For Climate Innovation Sprint Partner; Brings $40m In InvestmentGlobal AgInvesting•Sep 02, 2022•Aleph Farms, L Catterton, Strauss Group, VisVires New Protein and 4 others
